Biol Psychiatry
- SIDDIQI SH, Fox MD
Targeting Symptom-Specific Networks With Transcranial Magnetic Stimulation.
Biol Psychiatry. 2024;95:502-509.
Exp Neurol
- FU X, Qu L, Xu H, Xie J, et al
Ndfip1 protected dopaminergic neurons via regulating mitochondrial function and
ferroptosis in Parkinson's disease.
Exp Neurol. 2024;375:114724.
J Neurochem
- KALINICHENKO LS, Kohl Z, Muhle C, Hassan Z, et al
Sex-specific pleiotropic changes in emotional behavior and alcohol consumption in
human alpha-synuclein A53T transgenic mice during early adulthood.
J Neurochem. 2024;168:269-287.
Mov Disord
- OJO OO, Bandres-Ciga S, Makarious MB, Crea PW, et al
GBA1 rs3115534 Is Associated with REM Sleep Behavior Disorder in Parkinson's
Disease in Nigerians.
Mov Disord. 2024 Feb 23. doi: 10.1002/mds.29753.
- DORSEY ER, Kinel D, Pawlik ME, Zafar M, et al
Dry-Cleaning Chemicals and a Cluster of Parkinson's Disease and Cancer: A
Retrospective Investigation.
Mov Disord. 2024 Feb 23. doi: 10.1002/mds.29723.
Neurochem Res
- XU F, Bian N, Li X
SNHG14 Elevates NFAT5 Expression Through Sequestering miR-375-3p to Promote
MPP + -Induced Neuronal Apoptosis, Inflammation, and Oxidative Stress in
Parkinson's Disease.
Neurochem Res. 2024 Feb 21. doi: 10.1007/s11064-024-04106.
PLoS One
- WAWRZICZNY E, Flinois B, Constant E, Brugalle E, et al
Dealing with the diagnosis of Parkinson's disease and its implications for couple
functioning in the early stage: An interpretative phenomenological analysis.
PLoS One. 2024;19:e0294240.
Proc Natl Acad Sci U S A
- RILEY MJ, Mitchell CC, Ernst SE, Taylor EB, et al
A model for stimulation of enzyme activity by a competitive inhibitor based on
the interaction of terazosin and phosphoglycerate kinase 1.
Proc Natl Acad Sci U S A. 2024;121:e2318956121.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016